An effective drug, orally delivered, with zero to extremely minor side effects should greatly ramp up the number of people that will try the treatment. I also think we charge less than Otezla. The current TV ads re: Otezla and it's side effects scare the crap out of many and IMO results in many living with their disease.
Do the above and quite a LARGE number of biologic users or possible users will switch over to Prurisol IMO.
All in all, we bury Otezla not only in performance but in numbers of people trying Prurisol.
Daubers, yes, agree much, wouldn't that be great, and with good enough data we could make more, and maybe at a lesser pps. The market is so big. We'll see soon enough.
News 
Market Data 
Discover 
